Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. Most relevant
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ASTELLAS PHARMA INC.
03/12ASTELLAS PHARMA : Submits Drug Application for Enfortumab Vedotin in Japan
MT
03/11Japanese shares rise on economic optimism, tech rebound
RE
03/11ASTELLAS PHARMA : Submits New Drug Application for Enfortumab Vedotin in Japan
PU
03/11Astellas Pharma Inc. Submits New Drug Application for Enfortumab Vedotin in J..
CI
03/11Japanese shares end higher as cyclicals rally; heavyweights' decline caps gai..
RE
03/10Japanese shares gain on cyclicals boost, selling in some heavyweights weighs
RE
03/09Japan stocks end higher on hopes of economic rebound
RE
03/08Japanese shares rise amid stock rotation ahead of financial year-end
RE
03/05EDISON INVESTMENT RESEARCH LIMITED : Basilea Pharmaceutica (BSLN): Derazantinib ..
DJ
03/03VIVENDI : The Good Results for 2020 Confirm the -6-
DJ
03/01ASTELLAS PHARMA : Notice Regarding Continuation of the Performance-linked Stock ..
AQ
02/26ASTELLAS PHARMA : Notice Regarding Continuation of the Performance-linked Stock ..
PU
02/25ESSA Pharma Inc. Enters into Clinical Collaboration and Supply Agreement with..
CI
02/24PRESS RELEASE : Creative Balloons closes EUR15 million growth financing and appo..
DJ
02/22ASTELLAS PHARMA : Announces Positive Topline Results from Two Phase 3 Pivotal Gl..
AQ
02/19ASTELLAS PHARMA : and Seagen Announce Submission of Two Supplemental Biologics L..
AQ
02/18Astellas Pharma Inc. Announces Positive Topline Results from Two Phase 3 Pivo..
CI
02/15SEAGEN : and Astellas Announce Phase 3 Trial Results Demonstrating Survival Adva..
AQ
02/15ASTELLAS PHARMA : and Seagen Announce Presentation of Results from PADCEV Pivota..
AQ
02/09Japan shares edge higher driven by Honda's upbeat earnings outlook
RE
02/04Astellas Announces Executive Changes
CI
02/04ASTELLAS PHARMA : XOSPATA Receives Conditional Approval by China's National Medi..
AQ
02/04ASTELLAS PHARMA : Announces Management Structure
AQ
02/04PRESS RELEASE : MIG funds increases BioNTech dividend payments to a record EUR60..
DJ
02/03Astellas' XOSPATA® (gilteritinib) Receives Conditional Approval by China's Na..
CI
02/01ASTELLAS PHARMA : Returns Rights to EligardTM in Europe, Middle East, CIS, and A..
AQ
02/01ASTELLAS PHARMA : Posts Lower Profit in October-December 2020
MT
01/28Astellas Pharma Inc. Provides Earnings Guidance for the Fiscal 2021
CI
01/28Astellas Pharma Inc. Reports Consolidated Earnings Results for the Nine Month..
CI
01/28ASTELLAS PHARMA INC. : - Result of Open Innovation Challenge 'Astellas Rx+ Healt..
AQ
01/25ASTELLAS PHARMA : Builds New Manufacturing Lines for Aseptic Drugs at Yaizu Tech..
MT
01/25ASTELLAS PHARMA INC. : - Establishing New Manufacturing Lines for Aseptic Drug P..
AQ
01/25Japanese shares gain tracking U.S. futures; tech and pharma stocks boost
RE
01/25Astellas Pharma Inc. Establishes New Manufacturing Lines for Aseptic Drug Pro..
CI
01/24Japanese shares track U.S. futures higher, tech leads gains
RE
01/14ACTINIUM PHARMACEUTICALS : and Astellas Announce Research Collaboration Focused ..
AQ
01/13Actinium and Astellas Announce Research Collaboration Focused on Novel Actini..
CI
01/06Astellas Pharma Inc. Announces FDA Accepts for Priority Review the New Drug A..
CI
01/06ASTELLAS PHARMA INC. : - FDA Accepts for Priority Review the New Drug Applicatio..
AQ
2020ASTELLAS PHARMA : FDA Lifts Clinical Hold for Audentes Therapeutics' AT132 Trial
MT
2020ASTELLAS PHARMA : Reports XOSPATA in Combination with Azacitidine Did Not Meet E..
AQ
2020Astellas Reports XOSPATA in Combination with Azacitidine Did Not Meet Endpoin..
CI
2020ASTELLAS PHARMA : Supports Recommendations of Task Force on Climate-related Fina..
AQ
2020ASTELLAS PHARMA INC. : - Expansion of the Domestic Logistics Platform for Pharma..
AQ
2020Astellas Pharma Looks for Acquisitions
CI
2020VIATRIS : Astellas and Viatris Announce Termination of Co-promotion, Succession ..
AQ
2020Japan shares slip for third day; all eyes on U.S. stimulus debate
RE
2020Japanese shares slip back as investors look to U.S. stimulus debate
RE
2020ASTELLAS PHARMA : Viatris Pharmaceuticals Japan to End Joint Sales Promotion of ..
MT
2020KaliVir Immunotherapeutics LLC and Astellas Pharma Inc. Enter Worldwide Exclu..
CI
2020Astellas Receives Approval of EVRENZO in Japan for the Treatment of Anemia of..
AQ
2020ASTELLAS PHARMA : Europe Transfers DIFICLIR Market Authorizations in EMEA, Selec..
MT
2020ASTELLAS PHARMA : Gets Approval for EVRENZO in Japan
MT
2020Astellas and FibroGen Receive Approval of EVRENZO® in Japan for the Treatment..
CI
2020ASTELLAS PHARMA : Launches a 'Contact for Potential Acquisition of ' R&D Program..
AQ
2020Japan shares fall as virus surge, firmer yen weigh
RE
2020ASTELLAS PHARMA : to Present New Data on Gilteritinib in FLT3 Mutation-Positive ..
AQ
2020Astellas Pharma Inc. to Present New Data on Gilteritinib in FLT3 Mutation-Pos..
CI
2020ASTELLAS PHARMA : in Absorption-Type Merger with Two Subsidiaries
MT
2020ASTELLAS PHARMA INC. : - XTANDI Approved by China NMPA for the Treatment of Non-..
AQ
2020Astellas Pharma Inc. Announces Approval of XTANDI by China National Medical P..
CI
2020ASTELLAS PHARMA : Completes Acquisition of iota Biosciences
AQ
2020ASTELLAS PHARMA : Acquires Iota Biosciences
MT
2020Japan stocks fall, post biggest weekly loss in 3 months on virus worries
RE
2020Astellas Pharma Inc. Revises Earnings Guidance for the Year Ending March 31, ..
CI
2020Astellas Pharma Inc. Announces Consolidated Earnings Results for the Third Qu..
CI
2020Japanese shares slump on virus worries, mixed earnings
RE
2020Astellas Pharma Inc. completed the acquisition of remaining unknown majority ..
CI
2020ASTELLAS PHARMA : Receives U.S. FDA Fast Track Designation for ASP5354, an Inves..
AQ
2020Astellas Receives U.S. FDA Fast Track Designation for ASP5354, an Investigati..
CI
2020ASTELLAS PHARMA : ITI Announces Promotion of Dr. Tim Coleman to SVP, Operations ..
AQ
2020ASTELLAS PHARMA INC. : - U.S. FDA Grants Fast Track Designation for ASP0367/MA-0..
AQ
2020ASTELLAS PHARMA INC. : - New Roxadustat Data in Anemia of Chronic Kidney Disease..
AQ
2020U.S. FDA Grants Fast Track Designation for Astellas Pharma Inc.'s ASP0367/MA-..
CI
2020ASTELLAS PHARMA : China Update – Drug Patents
AQ
Prev.1   2  3  4  5  6  7  8  9  10Next
Upcoming event on ASTELLAS PHARMA INC.
07/23/21